Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Regulus Therapeutics (RGLS)

1.35 -0.05 (-3.57%)

5/25/2017  4:00pm

Open:

1.40

Pre. Close:

1.40

High:

1.42

Low:

1.30

Volume:

2,107,994

Market Cap:

71.80M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.44 - 1.47

1.47 - 1.49

Low:

1.24 - 1.26

1.26 - 1.27

Close:

1.3 - 1.35

1.35 - 1.38

Technical analysis  (as of: 2017-05-25 4:49:26 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 1.90     One year: 2.28

Support:

Support1: 1.10    Support2: 0.92

Resistance:

Resistance1: 1.63    Resistance2: 1.95

Pivot:

1.50

Moving Averages:

MA(5): 1.40     MA(20): 1.55

MA(100): 1.56     MA(250): 2.67

MACD:

MACD(12,26): -0.04     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 38.96     %D(3): 38.28

RSI:

RSI(14): 41.32

52-Week:

High: 6.25  Low: 0.94  Change(%): -76.7

Average Vol(K):

3-Month: 1080  10-Days 725

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
RGLS has closed above bottom band by 18.4%. Bollinger Bands are 18.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 25 May 2017 13:18:45 GMT
Factors to Note Before Buying Regulus Therapeutics Inc. (RGLS)

Thu, 25 May 2017 16:41:15 GMT
Option Trading: Regulus Therapeutics Inc Winning Long Put Spreads Can ...

Thu, 04 May 2017 20:26:15 GMT
Regulus Reports First Quarter 2017 Financial Results and Corporate Restructuring

Wed, 24 May 2017 11:48:45 GMT
Regulus Therapeutics Inc (RGLS) Short Interest Update

Thu, 27 Apr 2017 20:03:45 GMT
Regulus to Provide First Quarter 2017 Financial Results on May 4, 2017

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

52.00

Shares Float (M)

39.53

% Held by Insiders

42.92

% Held by Institutions

65.50

Shares Short (K)

2930

Shares Short Prior Month (K)

2870

Stock Financials

EPS

-1.550

EPS Est. Current Year

-1.350

EPS Est. Next Year

-0.830

EPS Est. Next Quarter

-0.270

Forward EPS

Book Value (p.s.)

1.060

PEG Ratio

-0.03

Profit Margin

Operating Margin

-6825.96

Return on Assets (ttm)

-42.1

Return on Equity (ttm)

-90.8

Qtrly Rev. Growth

-99.8

Gross Profit (p.s.)

0.022

Sales Per Share

0.014

EBITDA (p.s.)

-1.486

Qtrly Earnings Growth

Operating Cash Flow (M)

-56.88

Levered Free Cash Flow (M)

-27.49

FoxReading.com

Valuation

P/E

-0.87

P/E Growth Ratio

-0.04

P/BV

1.27

P/S

97.10

P/CF

-1.23

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.